Unlocking The Full Potential Of AAV-Mediated Gene Delivery (Cell & Gene)
Related Articles
July 21, 2026
Restore Vision and Forge Announce AAV Manufacturing Partnership
“Providing a new visual restoration treatment option for patients living with retinitis pigmentosa is central to our mission,” said Yusaku Katada, M.D.,...
June 16, 2026
Skylark Bio and Forge Announce Strategic AAV Development and cGMP Manufacturing Partnership
Under the partnership, Forge is providing Skylark with process development, current good manufacturing practice (cGMP) manufacturing, and analytical...
May 11, 2026
Forge Announces Seven Presentations at the ASGCT 29th Annual Meeting
“At ASGCT, we’re proud to showcase how our FUEL™ platform is enabling more doses per batch, improving scalability for broader...
May 5, 2026
Epicrispr Biotechnologies and Forge Announce AAV Development and cGMP Manufacturing Partnership
Epicrispr Biotechnologies and Forge announce a strategic partnership to support the development and manufacturing of...